F.D.A. Issues Warning of Cancer Risk Linked to CAR-T Therapies

Health
By Christina Jewett from NYT Health https://ift.tt/oTYJtfS
via IFTTT Cancer, Immunotherapy, Blood, Deaths (Fatalities), Genetic Engineering, Labeling and Labels (Product) The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.

Comments

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women